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Abstract
Introduction: The RIFLE (risk, injury, failure, loss of kidney function, and end-stage renal failure) classification for
acute kidney injury (AKI) was recently modified by the Acute Kidney Injury Network (AKIN). The two definition
systems differ in several aspects, and it is not clearly determined which has the better clinical accuracy.
Methods: In a retrospective observational study we investigated 4,836 consecutive patients undergoing cardiac
surgery with cardiopulmonary bypass from 2005 to 2007 at Mayo Clinic, Rochester, MN, USA. AKI was defined by
RIFLE and AKIN criteria.
Results: Significantly more patients were diagnosed as AKI by AKIN (26.3%) than by RIFLE (18.9%) criteria (P <
0.0001). Both definitions showed excellent association to outcome variables with worse outcome by increased
severity of AKI (P < 0.001, all variables). Mortality was increased with an odds ratio (OR) of 4.5 (95% CI 3.6 to 5.6) for
one class increase by RIFLE and an OR of 5.3 (95% CI 4.3 to 6.6) for one stage increase by AKIN. The multivariate
model showed lower predictive ability of RIFLE for mortality. Patients classified as AKI in one but not in the other
definition set were predominantly staged in the lowest AKI severity class (9.6% of patients in AKIN stage 1, 2.3% of
patients in RIFLE class R). Potential misclassification of AKI is higher in AKIN, which is related to moving the 48-hour
diagnostic window applied in AKIN criteria only. The greatest disagreement between both definition sets could be
detected in patients with initial postoperative decrease of serum creatinine.
Conclusions: Modification of RIFLE by staging of all patients with acute renal replacement therapy (RRT) in the
failure class F may improve predictive value. AKIN applied in patients undergoing cardiac surgery without
correction of serum creatinine for fluid balance may lead to over-diagnosis of AKI (poor positive predictive value).
Balancing limitations of both definition sets of AKI, we suggest application of the RIFLE criteria in patients
undergoing cardiac surgery.
Introduction
The consensus criteria for acute kidney injury (AKI)
developed by the Acute Dialysis Quality Initiative
(ADQI) group, first published in 2004 [1] and named
with the acronym RIFLE (risk, injury, failure, loss of kid-
ney function, and end-stage renal failure), represent the
first concerted effort to overcome the variety of different
definitions for AKI. More recently, a modified version
w a sp r o p o s e db yt h eA c u t eK i d n e yi n j u r yN e t w o r k
(AKIN) [2]. The two definition systems for AKI differ in
three major aspects. (I) In RIFLE the diagnosis is based
on changes over a one-week period, while AKIN
requires only changes within a designated 48-hour per-
iod. (II) Estimated glomerular filtration rate (eGFR) cri-
teria are not included in AKIN. The percentage change
from baseline serum creatinine (sCr) is identical in both
definitions, aside from the additional criterion of an
absolute sCr increment of ≥0.3 mg/dL within the AKIN
stage 1 category. (III) Renal replacement therapy (RRT)
in RIFLE was not assigned to a given severity class,
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stage 3 by AKIN. Urinary output criteria are identical by
both definition sets.
Our aim was to conduct a detailed comparison of
RIFLE and AKIN criteria in a cardiac surgical patient
cohort.
Materials and methods
Study population
After institutional review board approval (No. 09-
001950, study specific informed consent was waived),
we retrospectively investigated all patients who under-
went cardiac surgical procedures with cardiopulmonary
bypass (CPB) at Mayo Clinic Rochester within a three-
year period (2005 to 2007). Patient data were recorded
in a prospective computerized database. Patients with
dialysis prior to surgery or with baseline sCr >3.0 mg/dL
were excluded, as were those supported by extracorpor-
eal membrane oxygenation (ECMO) preoperatively,
patients undergoing cardiac/lung transplantation, assist
device insertion or thoracoabdominal aortic repair. In
accordance with Health Insurance Portability and
Accountability Act (HIPAA) guidelines, patients who
denied access to their medical records for the purpose
of research were not considered for analysis. In patients
who had more than one cardiac procedure with CPB
during the study period at our institution (n =4 2 )o n l y
data related to the first operation were included.
Patients who died intraoperatively or within 48 hours
postoperatively were excluded (n = 30). In addition to
available data each patient`s record was reviewed in
order to document the following variables for study pur-
poses: latest preoperative sCr values and sCr at each day
postoperatively up to day seven (POD (postoperative
day) 1 to 7). For baseline sCr the last value before sur-
gery was recorded. If more than one sCr was measured
per day in the postoperative period the highest recorded
value was used for study purpose. One patient was
excluded due to missing the preoperative sCr. The study
cohort consisted of 4,839 patients. Post-hoc three
patients were excluded who had RRT planned
postoperatively.
Data definitions
For the definition of AKI the sCr values at baseline and
on POD 1 to 7 were used. AKI was defined by the
RIFLE criteria using the maximal change in sCr and
estimated glomerular filtration rate (eGFR) during the
first seven postoperative days compared with baseline
values before surgery. eGFR was calculated with the
simplified Modification of Diet in Renal Disease
(MDRD) formula [3]. Patients were stratified according
to the highest RIFLE class R (Risk), I (Injury), or F (Fail-
ure) attained by sCr or eGFR criteria. Applying AKIN
criteria, the strict definition was used for increments of
sCr within a designated 48-hour interval (2). We com-
pared daily sCr value with subsequent levels for the next
two days until POD7 to create a moving 48-hour time
window (preoperative baseline to POD 1 and 2, POD 1
versus POD 2 and 3, and so forth). The most severe
degree of AKI was recorded as final AKIN stage. The
RIFLE and AKIN definition criteria utilized are summar-
ized in Table 1. The three thresholds for RIFLE and
AKIN are called “classes” and “stages”, respectively. All
thresholds of RIFLE also included any patient who
required RRT during the first seven days postoperatively
(POD 1 to 7), whereas by definition these patients were
l o c a t e di ns t a g e3b yA K I N .W ed i dn o tu s eu r i n eo u t -
put criteria in defining AKI.
Definitions for outcome variables were the following:
RRT as outcome variable included need for RRT during
the entire postoperative hospital stay or within 30 days
postoperatively. Operative mortality was in-hospital
mortality or 30-day mortality. Prolonged intubation
included those requiring ventilation for >24 hours post-
operatively. Length of hospital stay was defined in days
from index surgery to discharge.
Statistics
Descriptive statistics for categorical variables are reported
as frequency and percentage while continuous variables
are reported as mean ± standard deviation or median
(interquartile range) as appropriate. Categorical variables
were compared between RIFLE classes or AKIN stages
using Chi-square tests and continuous variables were
compared using ANOVA or Kruskal-Wallis test where
appropriate. Logistic regression models were used to pre-
dict the outcome variables mortality and prolonged intu-
bation using RIFLE or AKIN classifications. Linear
regression models were used to predict ICU length of
stay and hospital length of stay using RIFLE or AKIN
classifications. All tests were two-sided with the alpha
level set at 0.05 for statistical significance. Data were ana-
lyzed using SAS 9.1 software (SAS Inc., Cary, NC, USA).
Results
The final study cohort consisted of 4,836 consecutive
patients, median age was 67 years (range 18 to 100
years), 34% (n = 1,633) were women. Table 2 presents
detailed patient characteristics.
In 65% of patients maximal sCr values during the first
week postoperatively were detected during the first two
postoperative days. In the entire cohort 96 (2.0%)
patients had postoperative RRT, and 62/96 (65%) had
RRT within the first seven days postoperatively.
Significantly more patients were diagnosed as AKI
according to AKIN (n = 1,272, 26.3%) than by RIFLE
(n = 915, 18.9%) criteria (P < 0.0001). Distribution of
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the different grades of AKI severity by RIFLE classes
and AKIN stages are presented in Table 3.
Both definitions showed comparable and excellent
univariate association to all outcome variables with
worse outcome by increased severity of AKI, P < 0.001
for each variable (Table 4). Calculating the predictive
ability of both definition systems, RIFLE class as well as
AKIN stage were found to be significant predictors of
increased mortality, prolonged intubation, prolonged
ICU and hospital stay using multivariate analysis (P <
0.001 for all variables, Table 5). This was especially true
for the mortality endpoint, where patients had an odds
ratio of 4.5 (95% CI 3.6 to 5.6) for one class increase by
RIFLE and an odds ratio of 5.3 (95% CI 4.3 to 6.6) for
one stage increase by AKIN. Both definition sets of AKI
showed good discrimination for the prediction of mor-
tality as evaluated by the areas under the receiver opera-
tor characteristic curve (AUC): 0.80 (95% CI 0.75 to
0.85) for RIFLE and 0.82 (95% CI 0.77 to 0.87) for
AKIN, respectively (Table 5).
For the sake of further comparison, an explorative
post-hoc multivariate model was constructed including
all categories of RIFLE and AKIN. Consistent results
were seen for all outcome variables except mortality
(P < 0.001 for AKIN and without statistical significance
for RIFLE). In this explorative analysis, RIFLE seems to
have a lower predictive value for mortality than AKIN.
Patients who required postoperative RRT (irrespective
of staging by RIFLE or AKIN) had very poor outcomes
with a mortality of 44.8% (Table 6). We found substan-
tial disagreement between RIFLE and AKIN in classifica-
tion of patients who required RRT (Table 4). Out of all
patients with postoperative RRT, 63 (66%) had RRT
within the first seven postoperative days and were con-
secutively classified in AKIN stage 3, whereas only 18
(19%) of these patients were categorized in the failure
class by RIFLE. The other patients were distributed to
other RIFLE classes (Table 4).
It is important to note that whereas 9.6% of patients
classified as AKIN stage 1 had no-AKI by RIFLE, only
2.3% of patients in RIFLE class R had no-AKI by AKIN
(Table 3). These groups were investigated in detail. Both
populations demonstrated intermediate levels of the out-
come variables (Table 7). Baseline characteristics of both
of these groups showed significant differences compared
to the patient groups staged as no-AKI. No patient in
AKIN 1/RIFLE no-AKI group showed a sCr increase of
≥0.3 mg/dL within the seven postoperative days com-
pared to preoperative baseline, whereas such an incre-
ment was observed in 84/112 (75%) patients in the
RIFLE R/AKIN no-AKI group. AKI was over-diagnosed
by the AKIN definition.
Furthermore, separating patients according to initial
change in sCr between baseline and POD 1, and focus-
ing occurrence of AKI according to both definition sets,
the largest disagreement between RIFLE and AKIN was
found in the patient group who showed initial decrease
of sCr (Table 8). In contrary, only marginal differences
could be detected between final definition and staging
in RIFLE or AKIN in the patients who had initial
increase of sCr or stable sCr values (Table 8).
Discussion
The widespread acceptance of consensus definitions for
AKI is reflected in the increased utilization of both
RIFLE and AKIN criteria in the literature. In order to
progress further, establishment of a uniform definition
for AKI applicable in a variety of patient populations is
necessary. The aim of our study was to conduct an
indepth comparison between both consensus definitions
in a large retrospective cohort of patients undergoing
c a r d i a cs u r g e r ya tas i n g l ec e n t e ra n dt od e t e r m i n et h e
influence of the three modifications made from RIFLE
to AKIN. Our data demonstrate that important differ-
ences exist between the two classification schemes.
Existing comparative studies [4-10] are limited for dif-
ferent reasons. The main focus of comparison is most
often the ability of both definition systems to predict
outcome [4-10]. However, this was not the original
intention of a consensus definition for AKI. The initial
aim was to create a uniform definition to help
Table 1 Description of RIFLE [1] and AKIN [2] definition criteria for AKI used in analysis
Definition
System
AKI
RIFLE Class R (risk) Class I (injury) Class F (failure)
Seven-day
interval
sCr ≥1.5-fold increase or eGFR
>25% decrease compared to
baseline
sCr ≥2-fold increase or eGFR
>50% decrease compared to
baseline
sCr ≥3-fold increase or eGFR >75% decrease compared to
baseline, or sCr increase to ≥4 mg/dL in setting of an increase
of ≥0.5 mg/dL
AKIN Stage 1 Stage 2 Stage 3
48-hour
moving
window
sCr ≥1.5-fold increase or ≥ 0.3 mg/
dL
sCr ≥2-fold increase sCr ≥3-fold increase compared to baseline, or sCr increase to ≥4
mg/dL in setting of an increase of ≥0.5 mg/dL, or RRT
AKI, acute kidney injury; eGFR, estimated glomerular filtration rate; RRT, renal replacement therapy; sCr, serum creatinine.
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extent of renal dysfunction and to improve prophylactic
and therapeutic measures. Other limitations include var-
ious interpretations of the given criteria [4-10], hetero-
geneous time frames of observation [4-9], limitation of
comparison to changes in sCr not including GFR
thresholds [4-6,8-10], unknown RRT rates [4-6,10], and
finally the lack of sufficient number of patients to deter-
mine relevant differences [7,9,10].
In our cardiac surgical cohort, significantly more
patients were diagnosed as AKI by AKIN criteria than
by the RIFLE definition set. This reflects one of the
intentions of the Acute Kidney Injury Network to
increase the sensitivity of AKIN compared to RIFLE [2].
Among patients defined as AKI by both definitions
only limited disagreement occurred in the staging of
severity grade. More interestingly and clinically impor-
tant, the highest disagreement was found in the patient
groups defined as AKI by RIFLE but not by AKIN and
vice versa. In this situation either the definition system
failed to classify the patients as having AKI or a patient
was erroneously labeled with AKI but did not have the
condition. It is important to analyze these patients
further in detail.
The largest groups were identified in the lowest sever-
ity grades (Table 3). First, patients in both groups had
poorer outcome endpoints (versus no-AKI patients),
however, mortality rates did not differ significantly
(Table 7). Second, baseline characteristics of both sub-
groups (vs. no-AKI) demonstrated that differences in
outcome variables are possibly confounded by clinical
factors other than AKI. Finally we determined that the
overall differences between patients diagnosed as AKI
Table 2 Patient cohort characteristics
Entire cohort
(n = 4,836)
Demographics
Age, years 64.4 ± 14.2
Female sex, n (%) 1,633 (34)
Medical history
Diabetes, n (%) 981 (20)
Hypertension, n (%) 3,246 (67)
Chronic lung disease, n (%) 293 (13)
Extracardiac arteriopathy, n (%) 985 (20)
History of renal failure, n (%) 172 (4)
Baseline renal function
Baseline serum creatinine, mg/dL 1.13 ± 0.29
Patients with baseline serum creatinine
>2.0 mg/dL, n (%)
63 (1)
Baseline eGFR, mL/min/1.73 m
2 68 ± 19
Baseline eGFR >60 mL/min/1.73 m
2, n (%) 3,181 (66)
Baseline eGFR 31 to 60 mL/min/1.73 m
2, n (%) 1,596 (33)
Baseline eGFR ≤30 mL/min/1.73 m
2, n (%) 50 (1)
Preoperative cardiac status
Prior cardiac surgery, n (%) 721 (15)
LVEF >60%, n (%) 2,405 (50)
LVEF 41-60%, n (%) 1,655 (34)
LVEF 21-40, n (%) 442 (9)
LVEF ≤20%, n (%) 55 (1)
LVEF (missing value), n (%) 279 (6)
History of Myocardial infarction, n (%) 1,027 (21)
Congestive heart failure, n (%) 775 (16)
NYHA functional class IV, n (%) 913 (19)
Cardiogenic shock, n (%) 34 (1)
Preoperative IABP, n (%) 77 (2)
Preop on inotropes, n (%) 114 (2)
Operative details
CABG only, n (%) 1,258 (26)
CABG & Valve only, n (%) 566 (12)
Valve surgery, n (%) 1,196 (25)
Other/Combined surgery, n (%) 1,816 (37)
Elective surgery, (%) 3,947 (82)
Urgent surgery, n (%) 811 (17)
Emergent surgery & rescue, n (%) 78 (2)
CPB duration, minutes 85 ± 48
Cross-clamp time, minutes 58 ± 32
Patients with circulatory arrest, n (%) 220 (5)
Outcomes
Intra/postop IABP, n (%) 173 (4)
Intra/Postop ECMO or VAD, n (%) 20 (0.4)
Revision for bleeding, n (%) 192 (4)
Operative mortality, n (%) 89 (1.8)
Hospital length of stay (alive), days 6 (5 to 8)
Data are mean ± SD and median (interquartile range) unless otherwise specified.
CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; ECMO,
extracorporeal membrane oxygenation; eGFR, estimated glomerular filtration
rate; IABP, intra-aortic ballon pump; LVEF, left ventricular ejection fraction;
NYHA, New York Heart Association; VAD, ventricular assist device.
Table 3 Agreement of RIFLE and AKIN definitions
(numbers of patients and percentage of entire study
cohort)
Definitions by AKIN definition
no-AKI stage 1 stage
2
stage 3 total
by RIFLE
definition
no-
AKI
3,452 466 0 3 3,921
(71.4%) (9.6%) (0.06%) (81.1%)
class
R
112 582 5 16 715
(2.3%) (12.0%) (0.1%) (0.33%) (14.8%)
class
I
09 2 50 27 169
(1.9%) (1.0%) (0.56%) (3.5%)
class
F
012 28 31
(0.02%) (0.04%) (0.58%) (0.64%)
total 3,564 1,141 57 74 4,836
(73.7%) (23.6%) (1.2%) (1.5%) (100%)
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decrease of sCr from preoperative baseline to POD 1
(Table 8). In this group, post-operative sCr values that
were lower than preoperative levels could serve as com-
p a r i s o ni nt h e4 8 - h o u rm o v i ng diagnostic window of
AKIN. No patient in the AKIN 1/RIFLE no-AKI group
had a sCr increase of ≥0.3 mg/dL above the pre-opera-
tive baseline within the entire observation period which
is why the diagnosis of AKI is questionable (false-posi-
tive). The over-diagnosis of AKI by AKIN (accounting
for almost 10% in our study cohort) is clearly caused by
the moving 48-hour diagnostic interval and can be
avoided only by correction of creatinine for fluid accu-
mulation. This problem highlights the peculiarity of
patients where positive fluid balance is present (that is,
CPB with hemodilution). A physiological decrease in
sCr following cardiac surgery is well understood [8], and
our data demonstrate that this may have an important
influence on predicting subsequent development of AKI
(Table 8). Since no independent “gold standard” for the
definition of AKI is available, we performed in our study
the described three-step analysis.
The other patient group diagnosed as AKI class R by
RIFLE but not by AKIN, frequently had an increase of
sCr ≥0.3 mg/dL (84/122, 75%) compared to preoperative
baseline. AKI could not be detected by AKIN due to the
inability to obtain the critical threshold of ≥0.3 mg/dL
within a 48-hour window [11]. Thus, the number of
patients possibly misdiagnosed with AKI by AKIN is
more than four-fold higher (9.6% vs. 2.3%) than by the
application of the RIFLE criteria.
The moving 48-hour diagnostic window was intro-
duced in AKIN [2] in order to overcome the limitation
of RIFLE, that a diagnosis of AKI can be difficult when
a baseline sCr is unavailable. The initially proposed solu-
tion used the revised MDRD formula with a suggested
near lower limit of normal GFR (75 mL/minute/m2) to
estimate baseline sCr [1]. This has subsequently been
proven to perform well only when near-normal baseline
k i d n e yf u n c t i o ni sp r e s e n t[ 1 2 ] .I ts h o u l db en o t e dt h a t
preoperative sCr is available in most if not all patients
undergoing cardiac surgery. Additional justification for
the creation of a 48-hour diagnostic window was to
detect an abrupt increase in sCr [2].
Table 4 Outcomes by RIFLE and AKIN
RIFLE stage No-AKI class R class I class F P-value
n (%) 3,921 (81.1) 715 (14.8) 169 (3.5) 31 (0.64)
RRT, n (%) 8 (0.2) 33 (4.6) 37 (21.9) 18 (58.1) <0.001
Mortality, n (%) 25 (0.64) 27 (3.8) 31 (18.3) 6 (19.4) <0.001
Prolonged intubation (alive), n (%) 248 (6.4) 140 (20.3) 57 (41.3) 15 (60.0) <0.001
ICU length of stay (alive), hours 25 (21 to 45) 46 (23 to 93) 105 (53 to 192) 188 (77 to 323) <0.001
Hospital length of stay (alive), days 6 (5 to 7) 8 (6 to 11) 11 (8 to 21) 18 (10 to 27) <0.001
AKIN stage No-AKI stage 1 stage 2 stage 3 P-value
n (%) 3,564 (73.7) 1,141 (23.6) 57 (1.2) 74 (1.5)
RRT, n (%) 4 (0.1) 24 (2.1) 5 (8.8) 63 (85.1) <0.001
Mortality, n (%) 19 (0.53) 30 (2.6) 7 (12.3) 33 (44.6) <0.001
Prolonged intubation (alive), n (%) 211 (6.0) 204 (18.4) 17 (34.0) 28 (68.3) <0.001
ICU length of stay (alive), hours 25 (22 to 44) 44 (22 to 90) 72 (29 to 147) 210 (120 to 356) <0.001
Hospital length of stay (alive), days 6 (5 to 7) 7 (6 to 10) 10 (7 to 14) 19 (13 to 27) <0.001
Data are presented as median (interquartile range) if not otherwise stated.
RRT, renal replacement therapy.
Table 5 Predictive ability of RIFLE and AKIN for outcome variables by logistic regression model
Outcome Variable AKI Definition Level Odds Ratio (95% CI) P-value AUC (95% CI)
Mortality RIFLE per 1 class 4.5 (3.6 to 5.6) <0.001 0.80 (0.75 to 0.85)
AKIN per 1 stage 5.3 (4.3 to 6.6) <0.001 0.82 (0.77 to 0.87)
Prolonged intubation (alive) RIFLE per 1 class 3.3 (2.8 to 3.8) <0.001 0.66 (0.64 to 0.69)
AKIN per 1 stage 3.3 (2.8 to 3.8) <0.001 0.67 (0.64 to 0.69)
Estimate (95% CI) P-value
ICU length of stay (alive), hours RIFLE per 1 class 61 (54 to 68) <0.001
AKIN per 1 stage 59 (53 to 66) <0.001
Hospital length of stay (alive), days RIFLE per 1 class 4.3 (3.9 to 4.8) <0.001
AKIN per 1 stage 4.1 (3.7 to 4.6) <0.001
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with and without AKI may help to determine the validity
of a definition/staging system. Several authors have dis-
covered in a variety of patient cohorts that the thresholds
of AKI severity defined either with RIFLE [13-19] or
AKIN [20,21] were strongly associated with adverse
patient outcome. We also confirmed these findings in
our study. Interpretation of these findings is limited by
focusing on renal function because a strong association
does not prove a causal relationship. However, there is
increasing evidence that the kidney is not simply a pas-
sive bystander in multiorgan dysfunction [22].
Patients who require postoperative RRT have a very
poor outcome (Table 6). The different staging of
patients who had RRT within the first seven days after
surgery in the two definitions of AKI is very obvious
(Table 4). Both classification schemes demonstrated
good predictive value for outcome variables, however,
the stepwise incremental mor t a l i t yr i s kb yA K Is e v e r i t y
stage is better in AKIN. In this respect the predictive
value of RIFLE may increase if all patients with RRT are
staged in the highest possible class F, as done in the
AKIN definition set. Notably, three patients in our study
cohort staged in the highest severity class by AKIN but
in RIFLE classified as no-AKI (Table 3) did require post-
operative RRT.
The observation period for the diagnosis of AKI in our
study was limited to the first seven days postoperatively.
A longer time period might potentially alter our results,
however we feel this is unlikely because a) the median
postoperative stay of survivors was six days and b) AKI
beyond POD 7 is more likely influenced by postopera-
tive factors/complications than by renal injury during
index surgery. This is in accordance with the ADQI VI
consensus statement [23] where the authors advocate a
separation into “early” (within the first seven days) and
“late” cardiac surgery-associated AKI.
We have used sCr and GFR thresholds in calculating
RIFLE classes. Besides limited accuracy of eGFR in AKI
[24,25] it has been noted previously that the different
t h r e s h o l d sg i v e ni nR I F L Ef o rs C ri n c r e a s ea n de G F R
Table 6 Outcomes of patients who require postoperative
renal replacement therapy
AKIN stage No-RRT RRT P-
value
n = 4,740 96
Mortality, n (%) 46 (1.0) 43 (44.8) <0.001
Prolonged intubation (alive), n
(%)
419 (8.9) 41 (77.4) <0.001
ICU length of stay (alive), hours 25 (22 to
48)
351 (163 to
517)
<0.001
Hospital length of stay (alive),
days
6 (5 to 8) 26 (18 to 40) <0.001
Data are presented as median (interquartile range) if not otherwise stated.
Table 7 Comparison of outcomes and baseline variables in patients detected as AKI by AKIN but not by RIFLE or not
by AKIN but by RIFLE
No-AKI Group 1 Group 2 AKI P-value P-value
No-AKI by
RIFLE AND
AKIN
Patients with no-AKI
by RIFLE AND AKIN
stage 1
Patients with no-AKI
by AKIN AND RIFLE
class R
Patients in RIFLE
class R AND in AKIN
stage 1
Comparing
group no-AKI vs
group 1
Comparing
group no-AKI vs
group 2
n = 3452 466 112 582
Outcomes
Mortality, (%) 18 (0.5) 6 (1.3) 1 (0.9) 15 (2.6) 0.05 0.6
Prolonged
intubation
(alive), n (%)
191 (5.6) 56 (12.2) 20 (18.0) 116 (20.5) <0.001 <0.001
ICU length of
stay (alive),
hours
24 (21 to 44) 27 (22 to 60) 43 (23 to 91) 46 (23 to 94) <0.001 0.004
Hospital length
of stay (alive),
days
6 (5 to 7) 7 (6 to 9) 7 (6 to 9) 8 (6 to 11) <0.0001 0.006
Baseline
variables
Age, years 62.5 ± 14.4 67.9 ± 13.8 65.1 ± 12.8 - <0.001 0.09
LVEF, % 60 ± 12 57 ± 13 55 ± 14 - <0.001 <0.001
Baseline serum
creatinine, mg/
dL
1.09 ± 0.24 1.35 ± 0.37 0.86 ± 0.19 - <0.001 <0.001
Prior cardiac
surgery, n (%)
396 (11) 84 (18) 27 (24) - <0.001 <0.001
Data are presented as median (interquartile range) or mean ± SD if not otherwise stated.
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[26]. We have shown very recently in our study cohort,
that eGFR threshold (eGFR is directly dependent on
sCr) in RIFLE is more sensitive to classify AKI patients
than the sCr criteria [27]. This is in accordance with
data recently extracted from a pediatric patient cohort
[28]. In our study cohort, patients were classified as hav-
ing AKI in 9.3% with the sCr criteria versus 18.9% with
eGFR criteria, respectively. Thresholds for eGFR change
in RIFLE have higher sensitivity to detect patients in
class R and I, whereas changes in sCr show better sensi-
tivity for RIFLE class F [27]. As proposed in the original
RIFLE publication [1] our patients were allocated to the
worst possible RIFLE class they attained by either one
or another threshold. Using only the sCr criteria in
RIFLE may alter our results considerably.
We did not use urinary output criteria in our retro-
spective study. These criteria are identical in RIFLE and
AKIN for both amount of urinary output and reference
time period [1,2]. By urinary output criteria both defini-
tion sets may diagnose and stage patients in correspond-
ing severity classes which would not considerably
influence our comparative study design (except for a
few patients with RRT who may be located in a different
RIFLE class by urinary output criteria). Nevertheless, the
lack of urinary output data in our study has to be con-
sidered as a limitation, since there is a potential effect of
the use or non-use of the urinary output criterion [11].
In our study the strict AKIN criteria were applied in
the proscribed 48-hour moving window for diagnosis
and staging of AKI. However, in the original AKIN
paper the authors stated that “although diagnosis of AKI
is based on changes over the course of 48 hours, staging
occurs over a slightly longer time frame” [2]. Despite
this difference in time frames, the likelihood is that it
would not alter our results remarkably since the relevant
difference between AKIN and RIFLE was not detected in
the staging but in the diagnosis of AKI.
In a later publication [23], the ADQI group suggested
for the use of the AKIN definition in clinical practice that
the baseline reference sCr value in the postoperative
period should be at least measured more than 24 hours
after the start of surgery in order to prevent a diluted
serum sample being used as reference. In our study, we
did not apply strictly to this recommendation. However,
first postoperative sCr values collected for study purpose
were the sCr values measured the first day after surgery.
The sCr values at ICU admission at the day of surgery
were not considered in our study. We could demonstrate
that the majority of patients (Table 8) undergoing cardiac
surgery present lower sCr at the first postoperative day
compared to preoperative baseline. A relevant proportion
of patients may also have lower sCr compared to preo-
perative sCr on the following days. In this respect, the
above mentioned 24-hour rule seems to be arbitrary.
Nevertheless, it should be acknowledged when AKIN is
used as definition criteria for AKI in cardiac surgical
patients. In the cardiac surgical setting, when almost all
patients have known preoperative sCr values it seems to
be worthwhile to use this value as reference baseline
throughout the first seven days postoperatively, which is
in accordance with the RIFLE definition scheme.
One important finding of our study is the fact that
fluid accumulation has to be addressed for accurate
recognition and staging of AKI. In cardiac surgical
patients the AKIN definition scheme may potentially
lead to over-diagnosis of AKI. This is especially impor-
tant for epidemiologic studies when sCr values at ICU
admission after surgery serve as baseline values. It has
been recently demonstrated, however, that dilution of
sCr by fluid accumulation in critically-ill patients may in
contrast also lead to underestimation of the severity of
AKI and correction of sCr for fluid balance can improve
recognition and staging [29].
Our findings are applicable for the cardiac surgical
cohort and the detected differences between the both
definition schemes of AKI may differ in other setting.
Conclusions
In summary, balancing limitations and strengths of both
consensus definitions of AKI (in the current versions), we
favor the use of RIFLE criteria in patients undergoing
Table 8 Patients with acute kidney injury (AKI) according to serum creatinine changes between baseline and first
postoperative day (POD)
RIFLE AKIN
Creatinine change between baseline and
POD 1
Entire cohort
(n = 4,836)
No-AKI class R class I class
F
No-AKI stage
1
stage
2
stage
3
Increase, n (%) 1,090 (22) 523 (48) 422
(39)
122
(11)
23 (2) 515 (47) 487
(45)
32 (3) 56 (5)
No change, n (%) 955 (20) 792 (83) 134
(14)
25 (2.6) 4 (0.4) 775 (81) 165
(17)
10 (1) 5 (0.5)
Decrease, n (%) 2,791 (58) 2,606
(93)
159 (6) 22 (0.8) 4 (0.2) 2,274
(81)
489
(18)
15 (0.5) 13 (0.5)
Total, n (%) 4,836 (100) 3,921 715 169 31 3,563 1,142 57 74
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Page 7 of 9cardiac surgery. Modification of RIFLE by staging all
patients with acute RRT in the failure class F may improve
the predictive value of this classification scheme. AKIN
applied in patients undergoing cardiac surgery using the
suggested 48-hour diagnostic window without correction
of sCr for fluid balance may importantly lead to over-
diagnosis of AKI. The quest for a uniform definition for
AKI persists in its necessity and relevance [7,11,30].
Key messages
￿ The AKIN definition criteria applied in patients
undergoing cardiac surgery using the suggested 48-
hour diagnostic window without correction of sCr
for fluid balance may lead to over-diagnosis of AKI.
￿ Modification of RIFLE by staging all patients with
acute RRT in the failure class F may improve the
predictive value of this classification scheme.
￿ Balancing limitations and strengths of both con-
sensus definitions of AKI (in the current versions),
we favor the use of RIFLE criteria in patients under-
going cardiac surgery.
￿ Correction of sCr for fluid accumulation has to be
addressed for accurate recognition and staging
of AKI.
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